“[Budget Impact Analysis of Idarucizumab for the Management of Patients Treated With Dabigatran in Emergency Urgent Situations in Italy]”. Farmeconomia. Health Economics and Therapeutic Pathways, vol. 17, no. 2, June 2016, pp. 47-58, https://doi.org/10.7175/fe.v17i2.1243.